Susquehanna Portfolio Strategies, LLC
Position in A — Agilent Technologies, Inc.
CIK 1996449
Bala Cynwyd, PA
Position in A
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,586,801
+$5,497,239 QoQ
Shares Held
350,725
-2.7% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#95
of 1,112 holders
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Susquehanna Portfolio Strategies, LLC holds $96,079,544 across 8 Diagnostics & Research names. A ranks #1 (48.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
This page
|
350,725 | $46,586,801 | |
| 2 | GH |
Guardant Health, Inc.
|
155,346 | $23,306,560 | |
| 3 | DGX |
Quest Diagnostics Inc
|
60,404 | $12,802,627 | |
| 4 | TWST |
Twist Bioscience Corp
|
54,617 | $5,618,996 | |
| 5 | GRAL |
GRAIL, Inc.
|
71,088 | $4,853,177 | |
| 6 | PSNL |
Personalis, Inc.
|
121,299 | $1,625,406 | |
| 7 | CDNA |
CareDx, Inc.
|
45,122 | $1,285,977 | |
| 8 | ADPT |
Adaptive Biotechnologies Corp
|
54,788 | $0 |
All Filings in A
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,586,801 | 350,725 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $41,089,562 | 360,498 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $3,211,919 | 21,632 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $31,341,941 | 241,780 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $35,181,407 | 241,780 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $34,752,216 | 249,962 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||